Pfizer Inc. and Massachusetts Institute of Technology (MIT) Break Ground On New Research Units in Kendall Square

Published: Jan 09, 2012

NEW YORK and CAMBRIDGE, Mass., Nov 21, 2011 (BUSINESS WIRE) --

Pfizer Inc. and the Massachusetts Institute of Technology (MIT) today held the official groundbreaking of the new location of Pfizer's Cardiovascular, Metabolic and Endocrine Diseases (CVMED) and Neuroscience research units at 610 Main Street, Cambridge, MA.

Back to news